A pilot study of the Histone‐Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasmsAlessandro Rambaldi, Tiziano Barbui, Chiara Maria Dellacasa et al.|British Journal of Haematology|2010Cited by 242
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working GroupHolly L. Geyer, Peihong Zhang, Frank Stegelmann et al.|Haematologica|2016Cited by 73
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled DiseaseHolly L. Geyer, Jan Samuelsson, Robyn M. Scherber et al.|Journal of Clinical Oncology|2015Cited by 65
A Phase 2A study of the Histone-Deacetylase Inhibitor ITF2357 in Patients with Jak2V617F Positive Chronic Myeloproliferative NeoplasmsAlessandro Rambaldi, Tiziano Barbui, Chiara Maria Dellacasa et al.|Blood|2008Cited by 32
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needsAllison H. Scotch, Robert Peter Gale, Heidi Kosiorek et al.|Leukemia Research|2017Cited by 27